New patent for United Therap drug REMODULIN

Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are nine patents…
The post New patent for United Therap drug REMODULIN appeared first on Dr…


Which pharmaceutical drugs have the most drug patents in South Korea?

This chart shows the drugs with the most patents in South Korea. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical drugs have the most drug patents in South Korea?…


Biotechblog